News › Clinical Practice, Industry News, News

SofWave Medical’s Low-divergence Ultrasound Technology Receives FDA Clearance for Aesthetic Uses

September 20, 2019

Sofwave Medical Ltd., an emerging aesthetic device company, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Sofwave system. The Sofwave device is indicated for use as a non-invasive aesthetic treatment to improve facial lines and wrinkles.
The 510(k) clearance was supported by a blinded study of 59 subjects, demonstrating the safety and performance of the Sofwave System for non-invasive treatment to improve facial lines and wrinkles. The trial was led by principal investigators Dr. Roy Geronemus, New York, and Dr. Arielle Kauvar, New York.Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s
    • Allergan Aesthetics Debuts AA Signature in the United States with SKIN360
    • Candela Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • FDA Approves Additional Warning for Kybella Labeling
    • Federal Bill Would Establish New Ownership and Management Requirements for Medical Practices
Advertisement